New drug combo aims to fight tough head and neck cancers
NCT ID NCT04643379
Summary
This study is testing a new combination of three drugs—olaparib, pembrolizumab, and carboplatin—as the first treatment for people with advanced head and neck cancer that has returned or spread. The goal is to see if this three-drug mix can shrink tumors better than standard treatments. The trial will enroll about 30 adults with incurable disease to measure how well and for how long the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.